{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:44:06Z","timestamp":1694720646507},"reference-count":38,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.5551\/jat.43166","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T22:22:25Z","timestamp":1522189345000},"page":"1105-1117","source":"Crossref","is-referenced-by-count":5,"title":["Neopterin and Cardiovascular Events Following Coronary Stent Implantation in Patients with Stable Angina Pectoris"],"prefix":"10.5551","volume":"25","author":[{"given":"Tomotaka","family":"Yoshiyama","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sugioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Naruko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Yoshiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Morinomiya University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med, 1999; 340: 115-126","DOI":"10.1056\/NEJM199901143400207"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fuchs D, Weiss G, Wachter H: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol, 1993; 101: 1-6","DOI":"10.1159\/000236491"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC: Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation, 2004; 110: 1747-1753","DOI":"10.1161\/01.CIR.0000142664.18739.92"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Adachi T, Naruko T, Itoh A, Komatsu R, Abe Y, Shirai N, Yamashita H, Ehara S, Nakagawa M, Kitabayashi C, Ikura Y, Ohsawa M, Yoshiyama M, Haze K, Ueda M: Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart, 2007; 93: 1537-1541","DOI":"10.1136\/hrt.2006.109736"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sugioka K, Naruko T, Hozumi T, Nakagawa M, Kitabayashi C, Ikura Y, Shirai N, Matsumura Y, Ehara S, Ujino K, Itoh A, Haze K, Becker AE, Yoshiyama M, Ueda M: Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris. Atherosclerosis, 2010; 208: 524-530","DOI":"10.1016\/j.atherosclerosis.2009.07.054"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sun Y, He J, Tian J, Xie Z, Wang C, Yu B: Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study. Atherosclerosis, 2015; 241: 138-142","DOI":"10.1016\/j.atherosclerosis.2015.04.818"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC: Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J, 2005; 26: 457-463","DOI":"10.1093\/eurheartj\/ehi111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E: Long-term prognostic value of neopterin: a novel marker of monocyte activation inpatients with acute coronary syndrome. Circulation, 2007; 115: 3071-3078","DOI":"10.1161\/CIRCULATIONAHA.106.666511"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, Marrugat J, Mostaza J, Toro-Cebada R, Gonz\u00e1lez-Juanatey JR, Guzm\u00e1n-Mart\u00ednez G: Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis, 2008; 201: 176-183","DOI":"10.1016\/j.atherosclerosis.2008.01.009"},{"key":"10","unstructured":"10) Godai K, Uemasu J, Kawasaki H: Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol, 1991; 36: 141-146"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Est\u00e9vez-Loureiro R, Recio-Mayoral A, Sieira-Rodr\u00edguez-Moret JA, Trallero-Aragu\u00e1s E, Kaski JC: Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis, 2009; 207: 514-518","DOI":"10.1016\/j.atherosclerosis.2009.04.032"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Laynez-Cerde\u00f1a I, Kaski JC: Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis, 2010; 211: 574-578","DOI":"10.1016\/j.atherosclerosis.2010.04.017"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Naruko T, Ueda M, Ehara S, Itoh A, Haze K, Shirai N, Ikura Y, Ohsawa M, Itabe H, Kobayashi Y, Yamagishi H, Yoshiyama M, Yoshikawa J, Becker AE: Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol, 2006; 26: 877-883","DOI":"10.1161\/01.ATV.0000209886.31510.7f"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fukushima T, Nixon JC: Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem, 1980; 102: 176-188","DOI":"10.1016\/0003-2697(80)90336-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) van Dijk RA, Rijs K, Wezel A, Hamming JF, Kolodgie FD, Virmani R, Schaapherder AF, Lindeman JH. Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis. J Am Heart Assoc, 2016; 5: e002860","DOI":"10.1161\/JAHA.115.002860"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Van der Loos CM, Becker AE, van den Oord JJ: Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J, 1993; 25: 1-13","DOI":"10.1007\/BF00161039"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mori K, Ishida T, Tsuda S, Oshita T, Shinohara M, Hara T, Irino Y, Toh R, Hirata KI. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy. J Atheroscler Thromb, 2017; 24: 123-132","DOI":"10.5551\/jat.32615"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yeh JK, Chen CC, Hsieh MJ, Tsai ML, Yang CH, Chen DY, Chang SH, Wang CY, Lee CH, Hsieh IC. Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting. J Atheroscler Thromb, 2017; 24: 696-705","DOI":"10.5551\/jat.36434"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation, 1996; 94: 1247-1254","DOI":"10.1161\/01.CIR.94.6.1247"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE: Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation, 1998; 98: 224-233","DOI":"10.1161\/01.CIR.98.3.224"},{"key":"21","unstructured":"21) Ueda M, Becker AE, Kasayuki N, Kojima A, Morita Y, Tanaka S: In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol, 1996; 149: 831-843"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Naruko T, Itoh A, Haze K, Ehara S, Fukushima H, Sugama Y, Shirai N, Ikura Y, Ohsawa M, Ueda M: C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis, 2005: 181: 241-250","DOI":"10.1016\/j.atherosclerosis.2005.01.023"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shirai N, Naruko T, Ohsawa M, Ikura Y, Sugama Y, Hirayama M, Kitabayashi C, Ehara S, Inoue T, Itoh A, Haze K, Tanzawa K, Yoshiyama M, Yoshikawa J, Ueda M: Expression of endothelin-converting enzyme endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans. J Hypertens, 2006: 24: 711-721","DOI":"10.1097\/01.hjh.0000217854.97369.8c"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nakagawa M, Naruko T, Ikura Y, Komatsu R, Iwasa Y, Kitabayashi C, Inoue T, Itoh A, Yoshiyama M, Ueda M: A decline in platelet activation and inflammatory cell infiltration is associated with the phenotypic redifferentiation of neointimal smooth muscle cells after bare-metal stent implantation in acute coronary syndrome. J Atheroscler Thromb, 2010; 17: 675-687","DOI":"10.5551\/jat.3426"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R: Pathology of Acute and Chronic Coronary Stenting in Humans. Circulation, 1999; 99: 44-52","DOI":"10.1161\/01.CIR.99.1.44"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem, 1997; 272: 20963-20966","DOI":"10.1074\/jbc.272.34.20963"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Stiko-Rahm A, Hultg\u00e5rdh-Nilsson A, Regnstr\u00f6m J, Hamsten A, Nilsson J: Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb, 1992; 12: 1099-1109","DOI":"10.1161\/01.ATV.12.9.1099"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Widner B, Baier-Bitterlich G, Wede I, Wirleitner B, Fuchs D: Neopterin derivatives modulate the nitration of tyrosine by peroxynitrite. Biochem Biophys Res Commun, 1998; 248: 341-346","DOI":"10.1006\/bbrc.1998.8856"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hoffmann G, Schobersberger W, Frede S, Pelzer L, Fandrey J, Wachter H, Fuchs D, Grote J: Neopterin activates transcription factor nuclear factor-\u03baB in vascular smooth muscle cells. FEBS Lett, 1996; 391: 181-184","DOI":"10.1016\/0014-5793(96)00729-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Groth CG, B\u00e4ckman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattstr\u00f6m C, Charpentier B: Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and differenttoxicity compared with cyclosporine: Sirolimus European Renal Transplant Study Group. Transplantation, 1999; 67: 1036-1042","DOI":"10.1097\/00007890-199904150-00017"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH: Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol, 1990; 144: 251-258","DOI":"10.4049\/jimmunol.144.1.251"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ: Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation, 1999; 99: 2164-2170","DOI":"10.1161\/01.CIR.99.16.2164"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Eber B, Schumacher M, Tatzber F, Kaufmann P, Luha O, Esterbauer H, Gasser R, Klein W: Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty. Cardiovasc Drugs Ther, 1995; 9: 361-362","DOI":"10.1007\/BF00878683"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R: Pathology of second-generation everolimuseluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans. Circulation, 2014; 129: 211-223","DOI":"10.1161\/CIRCULATIONAHA.113.001790"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kawakami R, Hao H, Imanaka T, Shibuya M, Ueda Y, Tsujimoto M, Ishibashi-Ueda H, Hirota S: Initial pathological responses of second-generation everolimus-eluting stents implantation in Japanese coronary arteries: Comparison with first-generation sirolimus-eluting stents. J Cardiol, in press","DOI":"10.1016\/j.jjcc.2017.11.009"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol, 2011; 57: 1314-1322","DOI":"10.1016\/j.jacc.2011.01.011"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. Instent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol, 2012; 59: 2051-2057","DOI":"10.1016\/j.jacc.2011.10.909"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Chinetti-Gbaguidi G, Colin S, Staels B. Macrophage subsets in atherosclerosis. Nat Rev Cardiol, 2015; 12: 10-17","DOI":"10.1038\/nrcardio.2014.173"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/11\/25_43166\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T20:32:21Z","timestamp":1693600341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/11\/25_43166\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.43166","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}